Netupitant / Palonosetron Capsules Suppliers & Bulk Manufacturers
Available Forms: Capsules
Available Strengths: 300 mg netupitant and 0.5 mg palonosetron
Reference Brands: Akynzeo(US & EU)
Category: Antiemetic
Netupitant + Palonosetron capsules block neurokinin-1 and 5-HT3 receptors, respectively. This dual action prevents nausea and vomiting caused by chemotherapy. Benefits include long-lasting antiemetic control, improved patient comfort, fewer breakthrough symptoms, enhanced adherence to cancer treatments, and better quality of life during chemotherapy.
Product Description:
Netupitant + Palonosetron capsules, marketed as Akynzeo, are approved in the US by the FDA and in the EU via EMA for preventing chemotherapy-induced nausea and vomiting. Regulatory approval requires a detailed dossier including clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. The FDA reviews comprehensive clinical trial and quality data for timely approval, while the EMA ensures compliance with regional safety and manufacturing regulations. For guidance on dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Proper adherence supports swift approval, safe use, and global availability, helping cancer patients better manage nausea and improve treatment adherence worldwide.
Netupitant / Palonosetron Capsules — third party manufacturing & bulk supply
Netupitant / Palonosetron Capsules is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Netupitant / Palonosetron Capsules listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Netupitant / Palonosetron Capsules →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Netupitant / palonosetron is used to prevent nausea and vomiting associated with cancer chemotherapy. It is effective in preventing both acute and delayed chemotherapy-induced nausea and vomiting when given as part of an antiemetic regimen.
This combination contains two active substances: netupitant, a neurokinin-1 (NK1) receptor antagonist, and palonosetron, a serotonin (5-HT₃) receptor antagonist. Both are chemically synthesized and act on different pathways involved in nausea and vomiting.
The combination is marketed under the trade name Akynzeo.
Akynzeo was developed and is marketed by Helsinn Healthcare, with commercial partnerships in various regions.
The generic name is netupitant and palonosetron.
The primary brand name is Akynzeo.
Netupitant / palonosetron is manufactured in regulated pharmaceutical facilities across regions such as the EU and other approved markets, following international quality and regulatory standards.
Related Products
Ramosetron Hydrochloride
Strength:
0.1 mg
Form: Tablets
Reference Brands: Nasea (India), Ramoset (India)
View Details
Trimethobenzamide Hydrochloride
Strength:
200 mg , 200 mg/mL
Form: Capsules / Injection
Reference Brands: Tigan (USA)
View Details
Quick Response Guaranteed | Verified Suppliers
